ZielBio Competitors and Similar CompaniesClear all
ZielBio's competitors and similar companies include Copernicus Therapeutics, Domain Therapeutics and AEON Biopharma.
 ZielBio ZielBio is a biotechnology company that identifies novel disease targets and develops therapeutic interventions to improve patient outcomes. |  Copernicus Therapeutics Copernicus Therapeutics, Inc. (CTI) is a clinical-stage biopharmaceutical company specializing in precision medicine and gene therapy. |  AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. | ||
Founding Date | Founding Date 2012 | Founding Date 1998 | Founding Date 2001 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Charlottesville, US HQ | Locations Cleveland, US HQ | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Irvine, US HQ Newport Beach, US |
Employees | Employees 10 | Employees 6 | Employees 811% decrease | Employees 6 |
Funding | ||||
Latest funding round | Latest funding round $ 25.1m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 3.9m (about 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 25.1m | Total funding raised N/A | Total funding raised $ 41.5m | Total funding raised $ 112.6m |
For sources of this data, please see the company profile
View Company Profiles
Copernicus Therapeutics
HQ
Cleveland, US
Employees
6
Copernicus Therapeutics, Inc. (CTI) is a clinical-stage biopharmaceutical company specializing in precision medicine and gene therapy.
View company
Domain Therapeutics
HQ
Illkirch-Graffenstaden, FR
Employees
81↓ 1% decrease
Domain Therapeutics is a biopharmaceutical company.
View companyAEON Biopharma
HQ
Irvine, US
Employees
6
AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.
View company